Publications by authors named "Candice Campos"

3 Publications

  • Page 1 of 1

Variability among cardiologists in the management of patients under secondary prevention of ischemic heart disease.

Arq Bras Cardiol 2004 Sep 13;83(3):223-6; 219-22. Epub 2004 Sep 13.

Hospital de Clínicas de Porto Alegre, Ambulatório Especializado em Cardiopatia Isquêmica, Port Alegre, RS, Brazil.

Objective: To compare the management of patients with ischemic heart disease being followed up in a general cardiology outpatient clinic with that of patients being followed up in an outpatient clinic specific for ischemic heart disease, emphasizing the lipid profile and the pharmacological treatment prescribed.

Methods: Data were collected from the medical records of 52 patients consecutively treated in the outpatient clinic for ischemic heart disease (group I) and of 43 patients treated in the general cardiology outpatient clinic (group II), the anatomical diagnosis of ischemic heart disease being the basic condition for their inclusion in the study. The criteria for dyslipidemia were as follows: total cholesterol > or = 200 mg/dL or LDL-cholesterol > 100 mg/dL, or both, in patients using or not lipid-lowering drugs, and the use of lipid-lowering drugs, even when the total cholesterol or LDL-cholesterol levels were < 200 mg/dL and 100 mg/dL, respectively, or both. The Fisher exact test was used for comparing the variables, and a 2-tailed p < 0.05 was accepted as significant.

Results: Demographic characteristics, risk factors for ischemic heart disease, prevalence of previous myocardial infarction, and previous revascularization procedures showed no significant differences between the patients in groups I and II. In group I, 98% of the patients received aspirin, while, in group II, 83% of the patients received that drug (p = 0.02). In regard to the use of lipid-lowering drugs, the prevalences were 60% in group I and 19% in group II (p = 0.001). The lipid profile examination was requested for 98% of group I individuals and 79% of group II individuals (p = 0.003).

Conclusion: In regard to new medical evidence, mainly prescription of aspirin and lipid-lowering drugs, the management was more reliable in the outpatient clinic specifically aimed at treating ischemic heart disease.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
September 2004

Implications of the hemodynamic optimization approach guided by right heart catheterization in patients with severe heart failure.

Arq Bras Cardiol 2002 Mar;78(3):261-6

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brasil.

Objective: To report the hemodynamic and functional responses obtained with clinical optimization guided by hemodynamic parameters in patients with severe and refractory heart failure.

Methods: Invasive hemodynamic monitoring using right heart catheterization aimed to reach low filling pressures and peripheral resistance. Frequent adjustments of intravenous diuretics and vasodilators were performed according to the hemodynamic measurements.

Results: We assessed 19 patients (age = 48+/-12 years and ejection fraction = 21+/-5%) with severe heart failure. The intravenous use of diuretics and vasodilators reduced by 12 mm Hg (relative reduction of 43%) pulmonary artery occlusion pressure (P<0.001), with a concomitant increment of 6 mL per beat in stroke volume (relative increment of 24%, P<0.001). We observed significant associations between pulmonary artery occlusion pressure and mean pulmonary artery pressure (r=0.76; P<0.001) and central venous pressure (r=0.63; P<0.001). After clinical optimization, improvement in functional class occurred (P< 0.001), with a tendency towards improvement in ejection fraction and no impairment to renal function.

Conclusion: Optimization guided by hemodynamic parameters in patients with refractory heart failure provides a significant improvement in the hemodynamic profile with concomitant improvement in functional class. This study emphasizes that adjustments in blood volume result in immediate benefits for patients with severe heart failure.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
March 2002